SiteOne Therapeutics (Series C)
Funding Details
- Awarder
- Inbox
- Date Award
- December 18, 2024
- Vertical
- Biopharmaceuticals
- Funding URL
- View Funding Page
- Funding Amount:
- $100,000,000
Company Info
- Company Description
- SiteOne Therapeutics is a biopharmaceutical company developing selective ion channel modulators for the treatment of pain, cough, and other conditions.
- Market
- Pain, cough, and sensory hyperexcitability disorders
- Location
- South San Francisco, California, USA
- Coinvestors
- Novo Holdings, OrbiMed, Wellington Management, Mission BioCapital, BSQUARED Capital, existing investors